Here, for the first time, we demonstrate that increased CtBP1 promotes the infiltration of TAM and NSCLC progression significantly by activating increased production of CCL2 via the NF‐κB signalling pathway. The gene discussed is CCL2; the disease is non-small cell lung carcinoma.